Related Experiment Videos

Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer

R K Tiwari1, J Geliebter, V P Garikapaty

  • 1Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.

Insights

PC-SPES, an herbal preparation, demonstrated significant anti-tumor and anti-metastasis effects in a rat prostate cancer model. This suggests PC-SPES may be a beneficial adjuvant therapy for prostate cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Herbal Medicine

Background:

  • Prostate cancer is a leading cancer in developed countries, with metastatic disease being difficult to treat.
  • Novel therapeutic strategies are needed, particularly those combining conventional and alternative treatments.
  • PC-SPES is an herbal preparation with preliminary clinical evidence of reducing prostate-specific antigen levels.

Purpose of the Study:

  • To investigate the anti-tumor and anti-metastasis effects of PC-SPES in a rat prostate cancer model.
  • To assess the toxicity and efficacy of dietary PC-SPES.
  • To provide a foundation for developing standardized herbal treatment regimens.

Main Methods:

  • Utilized the Dunning R3327 rat prostate cancer model.
  • Administered PC-SPES orally via diet at 0.05% and 0.025% for six weeks.
  • Induced tumors using intradermal injections of MAT-LyLu cells, known for lung and lymph node metastasis.
  • Monitored tumor incidence, growth rate, and pulmonary metastases.

Main Results:

  • Dietary PC-SPES showed no toxicity or significant impact on food intake.
  • A dose-dependent inhibition of tumor incidence (P=0.01) and tumor growth rate was observed.
  • Animals responding to PC-SPES with no primary tumor growth also showed no lung metastases.
  • Non-responding animals showed no significant difference in pulmonary metastases compared to controls.

Conclusions:

  • PC-SPES exhibits significant anti-tumor and anti-metastasis effects in a relevant rat model.
  • These findings suggest PC-SPES may be a valuable therapeutic agent for prostate cancer.
  • PC-SPES could serve as a useful adjuvant therapy alongside conventional treatments for prostate cancer.

Related Concept Videos